Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,totalAssets,commonStock,retainedEarnings,treasuryStock,cash,totalCurrentLiabilities,otherStockholderEquity,totalCurrentAssets,netReceivables,longTermDebt,accountsPayable,changeToLiabilities,netBorrowings,totalCashFromFinancingActivities,changeInCash,totalCashFromOperatingActivities,depreciation,changeToAccountReceivables,changeToNetincome,repurchaseOfStock,otherCashflowsFromFinancingActivities,issuanceOfStock,totalCashflowsFromInvestingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,priceHint,exchange,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,exchangeDataDelayedBy,shortName,market,marketState,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,IMEXF,-1004857.0,8967190,208894,,-562260,,-562260,338724,0,-554965,-554965,,,,,,0,0,554965,0,-7295,,-562260,-562260,138235.0,1452516.0,-866622.0,585894.0,17393093.0,-21214424.0,2954709.0,54475.0,599332.0,2954709.0,447659.0,3463.0,853184.0,322595.0,49193.0,991812.0,991812.0,26857.0,-964955.0,7347.0,-346984.0,-112251.0,,,,,-151673.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.49,1630505450,0.02000001,0.4748,0.5201,0.47,20528,4.2553215,0.47 - 0.5201,0.47,0.0,0.0,0,0,finmb_306411869,Other OTC,Imagin Medical Inc.,CAD,6932,6014,0.47,23.5,0.02 - 1.17,-0.67999995,-0.58119655,0.02,1.17,1603756800,4,PNK,-0.342,-0.097,0.4030857,0.0869143,0.21562238,0.47847825,0.011521757,0.02408,4472186,-5.0515466,15,America/New_York,EDT,-14400000,False,False,0,IMAGIN MEDICAL INC,us_market,PRE,1.39,,,1.17,0.02,0.4031,0.4785,6.93k,6.01k,8.97M,,8.55M,5.74%,0.00%,,,,,,,,,,,0.00%,"Oct 26, 2020",,1:20,"Oct 26, 2020","Sep 29, 2020","Dec 30, 2020",0.00%,0.00%,-225.69%,"-189,224.67%",,,,,-3.27M,-3.7M,-0.3420,,54.48k,0.01,853.18k,,0.75,-0.10,-3.85M,-2.14M,Value,V6C 1L9,Healthcare,"Imagin Medical Inc. focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers i/Blue Imaging System, which is based on advanced optics and light sensors improve surgeons' ability to visualize cancerous cells for more accurate resection. The company's focus is on bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.",Vancouver,833 246 2446,BC,1609372800,Canada,http://imaginmedical.com,86400,890 West Pender Street,604 687 1327,Medical Devices,Suite 600
t-1,IMEXF,-476321.0,8967190,132031,,-689057,,-689057,456453,0,-603337,-603337,,,,,,0,0,603337,0,-85720,,-689057,-689057,145582.0,550139.0,-330739.0,219400.0,17366716.0,-20652164.0,2954709.0,27618.0,550139.0,2954709.0,73818.0,2325.0,,277644.0,397761.0,991812.0,991812.0,-241587.0,-241587.0,14853.0,34856.0,-112251.0,-1849982.0,1849982.0,,,-476321.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.49,1630505450,0.02000001,0.4748,0.5201,0.47,20528,4.2553215,0.47 - 0.5201,0.47,0.0,0.0,0,0,finmb_306411869,Other OTC,Imagin Medical Inc.,CAD,6932,6014,0.47,23.5,0.02 - 1.17,-0.67999995,-0.58119655,0.02,1.17,1603756800,4,PNK,-0.342,-0.097,0.4030857,0.0869143,0.21562238,0.47847825,0.011521757,0.02408,4472186,-5.0515466,15,America/New_York,EDT,-14400000,False,False,0,IMAGIN MEDICAL INC,us_market,PRE,1.39,,,1.17,0.02,0.4031,0.4785,6.93k,6.01k,8.97M,,8.55M,5.74%,0.00%,,,,,,,,,,,0.00%,"Oct 26, 2020",,1:20,"Oct 26, 2020","Sep 29, 2020","Dec 30, 2020",0.00%,0.00%,-225.69%,"-189,224.67%",,,,,-3.27M,-3.7M,-0.3420,,54.48k,0.01,853.18k,,0.75,-0.10,-3.85M,-2.14M,Value,V6C 1L9,Healthcare,"Imagin Medical Inc. focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers i/Blue Imaging System, which is based on advanced optics and light sensors improve surgeons' ability to visualize cancerous cells for more accurate resection. The company's focus is on bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.",Vancouver,833 246 2446,BC,1609372800,Canada,http://imaginmedical.com,86400,890 West Pender Street,604 687 1327,Medical Devices,Suite 600
t-2,IMEXF,197883.0,8967190,147847,,-582805,,-582805,324810,0,-478432,-478432,,,,,,0,0,478432,0,-104373,,-582805,-582805,160435.0,152378.0,358318.0,510696.0,17360362.0,-19963107.0,2961063.0,269205.0,152378.0,2961063.0,350261.0,3723.0,,119878.0,-179257.0,991812.0,50000.0,-634969.0,-684969.0,5775.0,71318.0,-112251.0,-1849982.0,1849982.0,50000.0,,197883.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.49,1630505450,0.02000001,0.4748,0.5201,0.47,20528,4.2553215,0.47 - 0.5201,0.47,0.0,0.0,0,0,finmb_306411869,Other OTC,Imagin Medical Inc.,CAD,6932,6014,0.47,23.5,0.02 - 1.17,-0.67999995,-0.58119655,0.02,1.17,1603756800,4,PNK,-0.342,-0.097,0.4030857,0.0869143,0.21562238,0.47847825,0.011521757,0.02408,4472186,-5.0515466,15,America/New_York,EDT,-14400000,False,False,0,IMAGIN MEDICAL INC,us_market,PRE,1.39,,,1.17,0.02,0.4031,0.4785,6.93k,6.01k,8.97M,,8.55M,5.74%,0.00%,,,,,,,,,,,0.00%,"Oct 26, 2020",,1:20,"Oct 26, 2020","Sep 29, 2020","Dec 30, 2020",0.00%,0.00%,-225.69%,"-189,224.67%",,,,,-3.27M,-3.7M,-0.3420,,54.48k,0.01,853.18k,,0.75,-0.10,-3.85M,-2.14M,Value,V6C 1L9,Healthcare,"Imagin Medical Inc. focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers i/Blue Imaging System, which is based on advanced optics and light sensors improve surgeons' ability to visualize cancerous cells for more accurate resection. The company's focus is on bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.",Vancouver,833 246 2446,BC,1609372800,Canada,http://imaginmedical.com,86400,890 West Pender Street,604 687 1327,Medical Devices,Suite 600
t-3,IMEXF,724913.0,8967190,1207381,,-1870290,,-1870290,419840,0,-1666935,-1666935,,,,,,0,0,1666935,0,-203355,,-1870290,-1870290,166210.0,331635.0,891123.0,1222758.0,17310362.0,-19380302.0,2961063.0,904174.0,331635.0,2961063.0,1056548.0,4822.0,,302135.0,-41730.0,991812.0,1849982.0,-142218.0,-1959055.0,5775.0,-93711.0,33939.0,-1849982.0,1849982.0,1849982.0,-33145.0,724913.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.49,1630505450,0.02000001,0.4748,0.5201,0.47,20528,4.2553215,0.47 - 0.5201,0.47,0.0,0.0,0,0,finmb_306411869,Other OTC,Imagin Medical Inc.,CAD,6932,6014,0.47,23.5,0.02 - 1.17,-0.67999995,-0.58119655,0.02,1.17,1603756800,4,PNK,-0.342,-0.097,0.4030857,0.0869143,0.21562238,0.47847825,0.011521757,0.02408,4472186,-5.0515466,15,America/New_York,EDT,-14400000,False,False,0,IMAGIN MEDICAL INC,us_market,PRE,1.39,,,1.17,0.02,0.4031,0.4785,6.93k,6.01k,8.97M,,8.55M,5.74%,0.00%,,,,,,,,,,,0.00%,"Oct 26, 2020",,1:20,"Oct 26, 2020","Sep 29, 2020","Dec 30, 2020",0.00%,0.00%,-225.69%,"-189,224.67%",,,,,-3.27M,-3.7M,-0.3420,,54.48k,0.01,853.18k,,0.75,-0.10,-3.85M,-2.14M,Value,V6C 1L9,Healthcare,"Imagin Medical Inc. focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers i/Blue Imaging System, which is based on advanced optics and light sensors improve surgeons' ability to visualize cancerous cells for more accurate resection. The company's focus is on bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.",Vancouver,833 246 2446,BC,1609372800,Canada,http://imaginmedical.com,86400,890 West Pender Street,604 687 1327,Medical Devices,Suite 600
